With extensive experience in venture capital, the fund manager has successfully navigated the technology and healthcare sectors, executing over 30 deals across North America and Europe. His strategic, data-driven approach has led to several notable exits, including a high-profile acquisition in the biotech space. Focused on early-stage investments, he emphasizes a thematic investment style that capitalizes on emerging market trends. His operator-first mindset fosters strong partnerships with portfolio companies, driving growth and innovation.